Pharmacokinetics of gatifloxacin mesylate tablet in healthy volunteers after multiple dosage administrations
YU Zeb
Abstract
YU Zeb
Abstract
Objective: To study the pharmacokinetics of gatifloxacin mesylate tablet in healthy volunteers after multiple dosage administrations. Methods:Multiple doses of 200 mg gatifloxacin once daily were administered orally for 7 days to 8 healthy volunteers, serum and urine concentrations of gatifloxacin were detected by high performance liquid chromatography. Results:Gati-floxacin was well tolerated in every subject. The concentration-time data were fitted to a two-compartment open model. On days 1 and 7, T max were 1.22 h and 1.35 h respectively, C max were 1.94 mg/L and 2.02 mg/L respectively, t 1/2β were 6.48 h and 7.89 h respectively, AUC 0-∞ were 20.54 mg·h/L and 19.81 mg·h/L respectively, 59.86 % of the given doses were recovered in the urine within 24 h after dosage. Conclusions:Gatifloxacin has favorable pharmacokinetic properties. Gatifloxacin 200 mg once or twice daily dosage may be applied in the treatment of bacterial infections caused by susceptible organisms.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the pharmacokinetics of gatifloxacin mesylate tablet in healthy volunteers after multiple dosage administrations. Methods:Multiple doses of 200 mg gatifloxacin once daily were administered orally for 7 days to 8 healthy volunteers, serum and urine concentrations of gatifloxacin were detected by high performance liquid chromatography. Results:Gati-floxacin was well tolerated in every subject. The concentration-time data were fitted to a two-compartment open model. On days 1 and 7, T max were 1.22 h and 1.35 h respectively, C max were 1.94 mg/L and 2.02 mg/L respectively, t 1/2β were 6.48 h and 7.89 h respectively, AUC 0-∞ were 20.54 mg·h/L and 19.81 mg·h/L respectively, 59.86 % of the given doses were recovered in the urine within 24 h after dosage. Conclusions:Gatifloxacin has favorable pharmacokinetic properties. Gatifloxacin 200 mg once or twice daily dosage may be applied in the treatment of bacterial infections caused by susceptible organisms.
Key concepts: Gatifloxacin, Pharmacokinetics, Urine, Pharmacology, Medicine, Chemistry, Internal medicine, Antibiotics